These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2556052)

  • 1. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.
    Dukes ID; Morad M
    Am J Physiol; 1989 Nov; 257(5 Pt 2):H1746-9. PubMed ID: 2556052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes.
    Wettwer E; Himmel HM; Amos GJ; Li Q; Metzger F; Ravens U
    Br J Pharmacol; 1998 Oct; 125(4):659-66. PubMed ID: 9831899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes.
    Berger F; Borchard U; Hafner D; Weis TM
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):291-8. PubMed ID: 9550301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed blockade of K+ and Na+ currents in rat ventricular myocytes by the tedisamil analogue, KC8851.
    McLarnon JG; Xu R
    Eur J Pharmacol; 1997 Nov; 339(2-3):279-88. PubMed ID: 9473146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tedisamil blocks single large-conductance Ca(2+)-activated K+ channels in membrane patches from smooth muscle cells of the guinea-pig portal vein.
    Pfründer D; Kreye VA
    Pflugers Arch; 1991 May; 418(4):308-12. PubMed ID: 1876480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tedisamil inhibits the delayed rectifier K+ current in single smooth muscle cells of the guinea-pig portal vein.
    Pfründer D; Kreye VA
    Pflugers Arch; 1992 May; 421(1):22-5. PubMed ID: 1630881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of glibenclamide, tedisamil, dofetilide, E-4031, and BRL-32872 on protein kinase A-activated chloride current in guinea pig ventricular myocytes.
    Faivre JF; Rouanet S; Bril A
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):551-7. PubMed ID: 9554804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito.
    Radicke S; Cotella D; Sblattero D; Ravens U; Santoro C; Wettwer E
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):617-26. PubMed ID: 19153714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tedisamil blocks BK-type Ca(2+)-dependent K(+) channels and modulates action potentials in rat hippocampal neurons.
    Church J; McLarnon JG
    Neurosci Lett; 2002 Feb; 319(2):79-82. PubMed ID: 11825675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the antifibrillatory compound tedisamil (KC-8857) on transmembrane currents in mammalian ventricular myocytes.
    Jost N; Virág L; Hála O; Varró A; Thormählen D; Papp JG
    Curr Med Chem; 2004 Dec; 11(24):3219-28. PubMed ID: 15579009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.
    Beatch GN; MacLeod BA; Abraham S; Walker MJ
    Proc West Pharmacol Soc; 1990; 33():5-8. PubMed ID: 2274546
    [No Abstract]   [Full Text] [Related]  

  • 18. Tedisamil: master switch of nature?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Jan; 10(1):129-38. PubMed ID: 11116286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    Turcani M; Thormaehlen D; Rupp H
    Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salutary effect of tedisamil on post-ischemic recovery rat heart: involvement of sarcolemmal (Na,K)-ATPase.
    Dzurba A; Ziegelhöffer A; Okruhlicová L; Vrbjar N; Styk J
    Mol Cell Biochem; 2000 Dec; 215(1-2):129-33. PubMed ID: 11204448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.